Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Sugar

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
JMIR Pediatrics and Parenting|June 22, 2023
Comprehension by Caregivers and Adolescents of Clinical Trial Information Delivered via Multimedia Video Versus Conventional Practice: Nonrandomized Controlled TrialKathryn V Blake, Holly Antal, H Timothy Bunnell, et al.
Sexually Transmitted Diseases|January 14, 2015
A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionDaniel C Beachler, Raphael Viscidi, Elizabeth A Sugar, et al.
Investigative Ophthalmology & Visual Science|January 17, 2012
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trialKevin D Frick, Lea T Drye, John H Kempen, et al.
Plos One|March 29, 2017
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
American Journal of Epidemiology|December 7, 2014
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adultsDaniel C Beachler, Elizabeth A Sugar, Joseph B Margolick, et al.
Plos One|November 11, 2016
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
The Journal of Infectious Diseases|May 9, 2015
High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV InfectionDaniel C Beachler, Yingshi Guo, Wiehong Xiao, et al.
Clinical Epigenetics|December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceThatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 22, 2020
Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)Sonali Bose, Christian Bime, Robert J Henderson, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
JMIR Pediatrics and Parenting|June 22, 2023
Comprehension by Caregivers and Adolescents of Clinical Trial Information Delivered via Multimedia Video Versus Conventional Practice: Nonrandomized Controlled TrialKathryn V Blake, Holly Antal, H Timothy Bunnell, et al.
Sexually Transmitted Diseases|January 14, 2015
A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionDaniel C Beachler, Raphael Viscidi, Elizabeth A Sugar, et al.
Investigative Ophthalmology & Visual Science|January 17, 2012
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trialKevin D Frick, Lea T Drye, John H Kempen, et al.
Plos One|March 29, 2017
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
American Journal of Epidemiology|December 7, 2014
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adultsDaniel C Beachler, Elizabeth A Sugar, Joseph B Margolick, et al.
Plos One|November 11, 2016
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled TrialRobert A Wise, Janet T Holbrook, Gerard Criner, et al.
The Journal of Infectious Diseases|May 9, 2015
High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV InfectionDaniel C Beachler, Yingshi Guo, Wiehong Xiao, et al.
Clinical Epigenetics|December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceThatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 22, 2020
Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)Sonali Bose, Christian Bime, Robert J Henderson, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Pageof 8